Valuation: Realcan Pharmaceutical Group Co., Ltd.

Market Cap 438.08Cr 65Cr 58Cr 54Cr 49Cr 93Cr 6.21TCr 94Cr 648.39Cr 254.22Cr 3.24TCr 245.71Cr 240.48Cr 10TCr P/E 2024
217x
P/E 2025 322x
Enterprise Value 524.11Cr 78Cr 70Cr 65Cr 59Cr 110.8Cr 7.43TCr 112.57Cr 775.72Cr 304.14Cr 3.88TCr 293.97Cr 287.71Cr 12TCr EV / Sales 2024
0.76x
EV / Sales 2025 0.77x
Free-Float
69.3%
Yield 2024
0.37%
Yield 2025 0.06%
1 day-1.65%
1 week-11.04%
Current month-8.87%
1 month-8.87%
3 months+9.16%
6 months-13.12%
Current year-7.45%
1 week 2.91
Extreme 2.91
3.27
1 month 2.91
Extreme 2.91
3.95
Current year 2.38
Extreme 2.38
4.11
1 year 2.38
Extreme 2.38
4.69
3 years 2.05
Extreme 2.05
4.69
5 years 2.05
Extreme 2.05
6.73
10 years 2.05
Extreme 2.05
18.26
Manager TitleAgeSince
Director of Finance/CFO 56 26/04/2021
President 61 26/05/2023
Corporate Officer/Principal 40 30/10/2019
Director TitleAgeSince
Chairman 61 21/11/2009
Director/Board Member 43 21/11/2009
Director/Board Member 71 19/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
12/05/23 Sell

Founder

1,50,00,000 1.2902%
30/03/23 Sell

Founder

1,30,40,000 1.1260%
30/03/23 Sell

Chairman

20,00,000 0.1727%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-11.04%+4.56%-12.35% 67Cr
-0.29%+6.26%+55.34%+112.70% 1,12000Cr
-1.15%-3.94%+30.78%+66.32% 62TCr
-0.03%+1.71%+23.22%+96.49% 50TCr
+0.30%+5.56%+35.18%+59.36% 37TCr
+0.01%+0.64%+69.58%+45.75% 36TCr
-0.48%+3.50%+19.22%+46.50% 29TCr
-0.15%+3.38%-1.05%+18.54% 26TCr
-0.32%+3.80%+42.89%+54.47% 23TCr
-0.06%+4.29%+27.44%+100.01% 19TCr
Average -0.33%+2.12%+30.72%+58.78% 39.42TCr
Weighted average by Cap. -0.25%+3.52%+38.37%+77.21%

Financials

2024 2025
Net sales 796.63Cr 119.06Cr 105.83Cr 98Cr 89Cr 168.41Cr 11TCr 171.11Cr 1.18TCr 462.29Cr 5.9TCr 446.82Cr 437.31Cr 19TCr 729.59Cr 109.04Cr 97Cr 90Cr 82Cr 154.23Cr 10TCr 156.71Cr 1.08TCr 423.38Cr 5.4TCr 409.21Cr 400.5Cr 17TCr
Net income 2.06Cr 30.82L 27.39L 25.39L 23.1L 43.59L 29Cr 44.29L 3.05Cr 1.2Cr 15Cr 1.16Cr 1.13Cr 49Cr 1.61Cr 24.02L 21.35L 19.79L 18L 33.97L 23Cr 34.52L 2.38Cr 93.26L 12Cr 90.14L 88.22L 38Cr
Net Debt 159.53Cr 24Cr 21Cr 20Cr 18Cr 34Cr 2.26TCr 34Cr 236.12Cr 93Cr 1.18TCr 89Cr 88Cr 3.76TCr 86Cr 13Cr 11Cr 11Cr 9.64Cr 18Cr 1.22TCr 18Cr 127.33Cr 50Cr 636.77Cr 48Cr 47Cr 2.03TCr
Projected Income Statement - Annual - Realcan Pharmaceutical Group Co., Ltd.
Logo Realcan Pharmaceutical Group Co., Ltd.
Realcan Pharmaceutical Group Co Ltd, formerly Realcan Pharmaceutical Co Ltd, is a China-based company mainly engaged in the provision of comprehensive medical service. The Company operates five businesses. The drug and device distribution business is mainly responsible for drug and device distribution services and comprehensive medical services. The in vitro diagnostic business covers all fields such as laboratory biochemistry, immunity, and clinical examination. The digital health business provides one-stop health management solutions. The pharmaceutical logistics business provides pharmaceutical and medical device logistics services. The traditional Chinese medicine business is engaged in the research, development and production of traditional Chinese medicine pieces, granules, new traditional Chinese medicines, liquefied traditional Chinese medicine products, and health foods. The Company mainly operates in the domestic market, with Shandong as its main market.
Employees
2,407
Date Price Change Volume
19/26/19 CN¥2.980 -1.65% 7,78,99,959
16/26/16 CN¥3.030 -1.62% 10,79,44,967
15/26/15 CN¥3.080 -2.22% 7,50,91,800
14/26/14 CN¥3.150 -3.37% 5,40,73,559
13/26/13 CN¥3.260 +0.62% 7,47,76,411
  1. Stock Market
  2. Stocks
  3. 002589 Stock